435 related articles for article (PubMed ID: 7651452)
1. "Off" painful dystonia in Parkinson's disease treated with botulinum toxin.
Pacchetti C; Albani G; Martignoni E; Godi L; Alfonsi E; Nappi G
Mov Disord; 1995 May; 10(3):333-6. PubMed ID: 7651452
[TBL] [Abstract][Full Text] [Related]
2. [A case of post-hemiplegic painful dystonia following thalamic infarction with good response to botulinus toxin].
Motoi Y; Hattori Y; Miwa H; Shina K; Mizuno Y
Rinsho Shinkeigaku; 1997 Oct; 37(10):881-6. PubMed ID: 9490897
[TBL] [Abstract][Full Text] [Related]
3. [Clinical characteristics of painful dystonic foot response in patients with Parkinson's disease].
Hara H; Wakayama Y; Kawase J
Rinsho Shinkeigaku; 1989 Sep; 29(9):1101-5. PubMed ID: 2598534
[TBL] [Abstract][Full Text] [Related]
4. [Parkinsonian dystonia].
Dowsey-Limousin P
Rev Neurol (Paris); 2003 Oct; 159(10 Pt 1):928-31. PubMed ID: 14615683
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin A injections for the treatment of hand tremors.
Trosch RM; Pullman SL
Mov Disord; 1994 Nov; 9(6):601-9. PubMed ID: 7845399
[TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin A--injection for cervical dystonia.
Bhaumik S; Behari M
J Assoc Physicians India; 1999 Mar; 47(3):267-70. PubMed ID: 10999117
[TBL] [Abstract][Full Text] [Related]
7. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
Wissel J; Entner T
Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
[TBL] [Abstract][Full Text] [Related]
8. Double-blind trial of botulinum toxin for treatment of focal hand dystonia.
Cole R; Hallett M; Cohen LG
Mov Disord; 1995 Jul; 10(4):466-71. PubMed ID: 7565828
[TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin treatment of lateral axial dystonia in Parkinsonism.
Bonanni L; Thomas A; Varanese S; Scorrano V; Onofrj M
Mov Disord; 2007 Oct; 22(14):2097-103. PubMed ID: 17685467
[TBL] [Abstract][Full Text] [Related]
10. Treatment of nonoccupational limb and trunk dystonia with botulinum toxin.
Quirk JA; Sheean GL; Marsden CD; Lees AJ
Mov Disord; 1996 Jul; 11(4):377-83. PubMed ID: 8813216
[TBL] [Abstract][Full Text] [Related]
11. Levodopa-induced dyskinesias in Parkinson's disease phenomenology and pathophysiology.
Marconi R; Lefebvre-Caparros D; Bonnet AM; Vidailhet M; Dubois B; Agid Y
Mov Disord; 1994 Jan; 9(1):2-12. PubMed ID: 8139601
[TBL] [Abstract][Full Text] [Related]
12. Time course of distant effects of local injections of botulinum toxin.
Garner CG; Straube A; Witt TN; Gasser T; Oertel WH
Mov Disord; 1993; 8(1):33-7. PubMed ID: 8380486
[TBL] [Abstract][Full Text] [Related]
13. Extensor truncal dystonia: successful treatment with botulinum toxin injections.
Comella CL; Shannon KM; Jaglin J
Mov Disord; 1998 May; 13(3):552-5. PubMed ID: 9613753
[TBL] [Abstract][Full Text] [Related]
14. Distant effects of local injection of botulinum toxin.
Lange DJ; Brin MF; Warner CL; Fahn S; Lovelace RE
Muscle Nerve; 1987; 10(6):552-5. PubMed ID: 3455658
[TBL] [Abstract][Full Text] [Related]
15. Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm.
Brin MF; Fahn S; Moskowitz C; Friedman A; Shale HM; Greene PE; Blitzer A; List T; Lange D; Lovelace RE
Mov Disord; 1987; 2(4):237-54. PubMed ID: 3504553
[TBL] [Abstract][Full Text] [Related]
16. BotB (botulinum toxin type B): evaluation of safety and tolerability in botulinum toxin type A-resistant cervical dystonia patients (preliminary study).
Truong DD; Cullis PA; O'Brien CF; Koller M; Villegas TP; Wallace JD
Mov Disord; 1997 Sep; 12(5):772-5. PubMed ID: 9380065
[TBL] [Abstract][Full Text] [Related]
17. Response to botulinum toxin F in seronegative botulinum toxin A--resistant patients.
Greene PE; Fahn S
Mov Disord; 1996 Mar; 11(2):181-4. PubMed ID: 8684389
[TBL] [Abstract][Full Text] [Related]
18. Change in lateralization of the P22/N30 cortical component of median nerve somatosensory evoked potentials in patients with cervical dystonia after successful treatment with botulinum toxin A.
Kanovský P; Streitová H; Dufek J; Znojil V; Daniel P; Rektor I
Mov Disord; 1998 Jan; 13(1):108-17. PubMed ID: 9452335
[TBL] [Abstract][Full Text] [Related]
19. Botulinum toxin in the treatment of dystonic tics.
Jankovic J
Mov Disord; 1994 May; 9(3):347-9. PubMed ID: 8041378
[TBL] [Abstract][Full Text] [Related]
20. Variability of the immunologic and clinical response in dystonic patients immunoresistant to botulinum toxin injections.
Sankhla C; Jankovic J; Duane D
Mov Disord; 1998 Jan; 13(1):150-4. PubMed ID: 9452341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
